Tc-99m exametazime (HMPAO)-labeled leukocyte scintigraphy in premature infants: detection and localization of necrotic enterocolitis and osteomyelitis
Language English Country United States Media print
Document type Case Reports, Journal Article
PubMed
21552012
DOI
10.1097/rlu.0b013e3182173954
PII: 00003072-201106000-00024
Knihovny.cz E-resources
- MeSH
- Isotope Labeling MeSH
- Infant MeSH
- Leukocytes diagnostic imaging MeSH
- Humans MeSH
- Enterocolitis, Necrotizing complications diagnostic imaging pathology physiopathology MeSH
- Osteomyelitis blood complications diagnostic imaging pathology physiopathology MeSH
- Premature Birth diagnostic imaging pathology physiopathology MeSH
- Radionuclide Imaging MeSH
- Technetium Tc 99m Exametazime * MeSH
- Pregnancy MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Technetium Tc 99m Exametazime * MeSH
Two cases of successful detection of inflammatory foci using Tc-99m exametazime (HMPAO)-labeled leukocyte scintigraphy in premature infants were reported. Necrotizing enterocolitis was detected in a child with a body weight of 1.6 kg. Scintigraphy confirmed a neonatal osteomyelitis in the distal part of the leg of another patient weighing 2.2 kg. These 2 cases indicate that it is feasible to perform Tc-99m HMPAO-labeled leukocyte scintigraphy even if the blood sample volume is lower than the minimal volumes required by the guidelines for pediatric patients.
References provided by Crossref.org
